About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Rejuvenation Research

Editor-in-Chief: Aubrey D.N.J. de Grey

ISSN: 1549-1684 • Published Bimonthly • Online ISSN: 1557-8577

Current Volume: 17

Latest Impact Factor* is 3.931

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Rejuvenation Research is an international, interdisciplinary, peer-reviewed academic journal that covers all aspects of biology and biomedicine relevant to the combating, and ultimately the reversal, of age-related physiological and cognitive decline, in nonhuman species and eventually in humans.  To help defray the cost of printing, the Publisher requests that page charges of $50 per printed page be paid by all authors who have funds available from research grants or from their institutions. It should be noted that ability to pay page charges is not a prerequisite for publication in the Journal.

    Only manuscripts that conform with guidelines contained herein will be considered for publication. All manuscripts are subject to peer review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication and have not already been published. Submission of an article for publication implies the transfer of the copyright from the author to the Publisher upon acceptance. Accepted papers become the permanent property of Rejuvenation Research and may not be reproduced by any means, in whole or in part, without the written consent of the Publisher.

    Liebert Instant Online (LION)

    To enable the release of new scientific findings as quickly as possible, the Journal has a policy of pre-publishing all manuscripts in their unedited format upon acceptance. The papers will have undergone full peer review but will not yet have been copyedited, typeset, or proofread/corrected by the authors. All accepted papers appear online within 72 hours of acceptance as a part of Liebert Instant Online (LION).

    Following its appearance on LION, the paper will progress through the normal production process, including author correction of galley proofs and online publication of the final edited and typeset manuscript ahead of print.

    It is essential to note that, as part of the LION program, the data that is published instantly online after acceptance – and in Medline – is pulled directly from the information that was populated into the fields in Manuscript Central upon submission not as listed in the manuscript Word document.   Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline/PubMed, until the next revision of the article is published.  It is therefore critically important to submit the correct names and email addresses of all authors under the "my authors" section when uploading your manuscript. This author list is what will be used for the Journal’s LION program and its initial listing on PubMed.

    No errors appearing on our website, or in Medline, can be corrected until the subsequent revision is published.

    The next revision will take place after the corresponding author reviews the page proofs, makes any necessary corrections, and returns the changes to the Publisher.  Once all alterations are made, the revised version will be published on our website, and the newly corrected information will be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.

    The typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.

    Publication Categories

    Research Articles

    Original reports of basic research on aging and ways to combat it.

    Clinical Articles

    Original clinical investigations in areas relevant to combating aging.

    Theoretical Articles

    Original essays which explore theoretical aspects of aging with a clear view toward eventual biomedical implications.

    Social Implications

    Original discussions of the sociopolitical, economic or ethical implications of extending the healthy and/or total human lifespan.


    Paired and opposing reviews of provocative issues in aging. Each author will be invited to write a short response to the opposing review. Reviews and responses will appear in the same issue.

    Literature Reviews

    Reviews of a topical area of research relevant to combating aging, discussing the work of multiple research groups.

    Meeting Reports

    Accounts of a representative sample of talks or poster presentations at a recent conference or symposium related to combating aging.


    Letters regarding articles published recently (in the two most recent issues) in Rejuvenation Research. Authors of such articles will be invited to respond to such letters in the same issue in which the letter is published.


    Manuscript Submission

    Manuscripts must be submitted online using the following url:


    Text must be submitted as a Microsoft Word document and figures as TIFF files at 600 dpi. Submit the text and figure legends as one file but do not include figures OR tables in the main file. Each figure and table should be submitted as a separate file.

    Note: All studies involving human or animal subjects should have approval or stated exemption from the author’s institutional review board or animal subject review committee. In research involving human subjects, informed consent must have been obtained in writing as well. Briefly describe the nature of such approval, exemption, or consent in the cover letter. Briefly specify the responsibility of each listed author or consultant in the research, preparation or writing.


    Double space only (not 1.5 spacing) and format for printing on 8.5 X 11-inch white paper with margins of at least one inch on all sides. Font size should be no smaller than 12 pt. Number each page, beginning with the title page. The parts of the manuscript should appear in the following order: title page, abstract, main text, acknowledgements, references, tables, figure legends.

    The maximum length for Literature Review papers is 6000 words (not including abstract, legends, and references); there should be no more than 150 references and six figures or tables. The maximum length for Correspondence is 1000 words; no more than 10 references and one figure or table. For all other categories the maximum length is 4000 words (not including abstract, legends and references), with no more than 70 references and seven figures or tables.

    Title Page

    Include the full title, authors’ names, authors’ full affiliation, information, the phrase “word count” followed by the number of words in the main text (excluding abstract, figures, legend, and references), the phrase “address for correspondence and reprints” followed by the full name, complete mailing address, telephone and fax numbers, and e-mail address of the communicating author, a list of between three and six keywords, and an abbreviated title of at most 45 characters including spaces.

    Please be sure to include all authors’ affiliations on the title page. An e-mail, telephone and fax numbers, and mailing address are required on the title page for the corresponding author only.


    The abstract should be no more than 250 words. Do not include any abbreviations or references in the abstract.

    Tables and Figures

    Each table or figure should be in a separate file. Table legends should appear above the table on the same page; figure legends should appear together at the end of the main document. The information portrayed in figures must be self-explanatory, containing sufficient information (together with the legend) that it can be understood clearly without reference to the text. Each figure should be clearly labeled within the figure itself, not just in the file name. Information should not be given in a table if it can be given in the text in one or two sentences. Illustrations can be printed in color upon subsidy from the author and are encouraged; contact the Publisher for details.

    Please follow these guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document.
    • Line illustrations should be submitted at 600 dpi.
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Save as either TIFF or EPS files.
    • Color art must be saved as CYMK - not RGB.
    • Black and White art must be submitted as grayscale – not RGB.
    • Do NOT submit PowerPoint, PDF, Bitmap or Excel files.

    Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not file these guidelines may have their submission returned to them without being reviewed.

    You will be given directions on how to correct any files which do not pass.


    Converting Word or Excel files:

    Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • All files should be scanned at 100% size
    • 300 dpi
    • Final color mode: cmyk
    • save file as: .tif or .eps
    If you need directions on how to convert a Power Point slide to acceptable format go to


    Disclosure Statement
    Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."


    Double space all references. Number each reference consecutively in the manuscript in order of citation. Number references consecutively (not alphabetically) in the reference section. Abbreviations of journal titles should follow MEDLINE.  List the names of all authors—do not use et al. Accuracy of citation is the responsibility of the authors; remember that inaccurate references are highly frustrating to the reader, the cited author, and indexing services.

    Examples of correct citation include:

    Journal article

    Finch CE, Tanzi RE. Genetics of aging. Science 1997; 278:407–411.


    Finch CE. Longevity, senescence and the genome. Chicago: University of Chicago Press, 1990.

    Book Chapter

    Rothstein G. White cell disorders. In: Hazzard WR, Bierman EL, Blass JP, et al. (eds.): Principles of Geriatric Medicine, 3rd Ed. New York: McGraw-Hill, 1994, pp. 749–762.

    Personal Communications

    If such a reference is necessary, include the name, title, month, and year as well as a letter granting permission to publish from the person providing the information. Personal communication references should be included in the reference list in order of citation.


    The author must obtain permission to reproduce figures, tables, or text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned and should be supplied to the Editor-in-Chief of Rejuvenation Research. An appropriate acknowledgement should be included to reflect the permission and full publication information cited in the references. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the submitted manuscript.


    Unless rejected for publication, all submissions become the property of Mary Ann Liebert, Inc.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


    Rejuvenation Research is owned and published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101.

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Antioxidants & Redox Signaling

    Antioxidants & Redox Signaling

    The leading resource for the latest research and information on antioxidants and redox biology. The Journal explores key aspects of the important and expanding world of redox-based therapeutics.

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Cellular Reprogramming

    Cellular Reprogramming

    Cutting-edge techniques and the latest high-quality research on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

Browse All Publications »